Caspofungin Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Caspofungin Acetate Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status To Be Discontinued. The shortage was first posted on 06/30/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 0781-3423-94
- Dosage Form
- Injection
- Presentation
- Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94)
- Initial Posting
- 06/30/2026
- Revised Date